Oct 27, 7:08 AM ET
IQVIA reported third-quarter 2026 revenue of $4,428 million, up 8.0%, and Adjusted Diluted EPS of $3.34, up 11.3% year-over-year. The company raised its full-year 2026 guidance for revenue, Adjusted EBITDA and Adjusted Diluted EPS, which is the key development for shareholders. The filing also discloses a backlog adjustment of approximately $2.1 billion tied to a review of inactive trials, which the company says does not affect 2026 guidance.
- Q3 revenue $4,428 million, up 8.0% reported and 8.6% at constant currency; GAAP diluted EPS $2.10 versus $1.93 a year earlier
- Full-year 2026 revenue guidance raised to $17,350 million to $17,500 million; Adjusted EBITDA to $4,025 million to $4,055 million
- Full-year 2026 Adjusted Diluted EPS guidance raised to $12.90 to $13.00
- Backlog adjusted by approximately $2.1 billion after review of inactive trials; R&DS contracted backlog stood at $32.6 billion as of September 30, 2026
Read the filing on SEC.gov ↗
Sep 23, 5:03 PM ET
IQVIA Inc., a wholly owned subsidiary of IQVIA Holdings, completed a $2 billion offering of 6.375% senior notes maturing March 15, 2034. Proceeds will redeem the issuer's 5.000% notes due 2026, repay part of its revolving credit facility and cover offering fees. The deal refinances existing debt and adds new long-term borrowing, which shareholders may weigh against the company's debt load.
- Gross proceeds of $2,000,000,000 from 6.375% senior unsecured notes due March 15, 2034
- Proceeds to redeem in full the Senior 5.000% Notes due 2026 and repay part of the revolving credit facility
- Interest payable semi-annually on March 15 and September 15, starting March 15, 2027
- Issuer may redeem before September 15, 2029 subject to a make-whole premium
Read the filing on SEC.gov ↗
Jul 28, 7:03 AM ET
IQVIA reported second-quarter 2026 revenue of $4,368 million, up 8.7% year-over-year, and adjusted diluted earnings per share of $3.15, up 12.1%. The company raised its full-year 2026 guidance for revenue, Adjusted EBITDA and Adjusted Diluted EPS, though GAAP net income and GAAP diluted EPS were slightly lower than a year earlier.
- Revenue was $4,368 million, up 8.7%; R&D Solutions net new bookings were $3.15 billion, up 19%, with a 1.22x book-to-bill ratio.
- GAAP diluted EPS was $1.53 versus $1.54 a year earlier; GAAP net income attributable to IQVIA was $256 million versus $266 million.
- Full-year 2026 revenue guidance was raised to $17,275 million–$17,475 million; Adjusted EBITDA to $4,000 million–$4,050 million; Adjusted Diluted EPS to $12.80–$13.00.
- The company repurchased $398 million of common stock in the second quarter and had $2,819 million of authorization remaining as of June 30, 2026.
Read the filing on SEC.gov ↗
Jun 11, 4:46 PM ET
IQVIA Inc., a wholly owned subsidiary of IQVIA Holdings, issued €950 million in senior notes maturing June 15, 2033, with proceeds used to refinance existing debt and pay offering fees. The notes add new unsecured debt to the company's obligations, though the filing does not describe the effect on total leverage.
- Issued €950,000,000 in gross proceeds of 4.625% senior notes due June 15, 2033, on June 11, 2026
- Interest payable semi-annually on June 15 and December 15, beginning December 15, 2026
- Proceeds to refinance certain existing indebtedness of the Issuer and pay offering fees and expenses
- Optional redemption before June 15, 2029 subject to a make-whole premium; premium steps down from 2.313% to 0.000% thereafter
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.